Reckitt Benckiser Group plc (LON:RKT – Get Free Report) insider Jeremy Darroch bought 1,652 shares of the business’s stock in a transaction on Tuesday, July 29th. The stock was purchased at an average price of GBX 5,649 ($74.90) per share, for a total transaction of £93,321.48 ($123,735.72).
Reckitt Benckiser Group Trading Up 0.4%
Shares of Reckitt Benckiser Group stock opened at GBX 5,672 ($75.21) on Thursday. The stock has a market cap of £38.70 billion, a P/E ratio of 25.96, a P/E/G ratio of 1.10 and a beta of 0.09. The company has a quick ratio of 0.46, a current ratio of 0.69 and a debt-to-equity ratio of 110.26. Reckitt Benckiser Group plc has a 12-month low of GBX 4,053 ($53.74) and a 12-month high of GBX 5,722 ($75.87). The business’s 50 day moving average is GBX 5,093.75 and its 200-day moving average is GBX 5,074.49.
Reckitt Benckiser Group (LON:RKT – Get Free Report) last posted its quarterly earnings results on Thursday, July 24th. The company reported GBX 141.20 ($1.87) earnings per share (EPS) for the quarter. Reckitt Benckiser Group had a net margin of 10.78% and a return on equity of 18.70%. Equities research analysts predict that Reckitt Benckiser Group plc will post 331.2110727 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Reckitt Benckiser Group Company Profile
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Further Reading
- Five stocks we like better than Reckitt Benckiser Group
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?
- What Are Dividend Contenders? Investing in Dividend Contenders
- How Marvell Went From Short Target to Breakout Star
- How to find penny stocks to invest and trade
- Palo Alto Networks: The All‑in‑One Cybersecurity Powerhouse
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.